Supplement × Prescription·a caution·Emerging evidence

Rasagiline + Rhodiola Rosea

Caution Emerging evidence

Rhodiola may have stimulant or monoaminergic effects that could add to MAO-B inhibition.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Pair type
Caution
Evidence
Emerging
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionEmerging evidence

What is happening. Rhodiola may have stimulant or monoaminergic effects that could add to MAO-B inhibition.

Mechanism. Potential additive monoaminergic stimulation during impaired monoamine metabolism.

Recommendation. Avoid unless the neurologist approves; monitor blood pressure, agitation, insomnia, and serotonergic symptoms.

Stack Score

How it moves the number.

Effect on the composite score

If both Rasagiline and Rhodiola Rosea are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1U.S. National Library of Medicine. Rasagiline tablets US Prescribing Information. 2026.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.